Cargando…
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
The reactive dicarbonyl metabolite methylglyoxal (MG) is the precursor of the major quantitative advanced glycation endproducts (AGEs) in physiological systems - arginine-derived hydroimidazolones and deoxyguanosine-derived imidazopurinones. The glyoxalase system in the cytoplasm of cells provides t...
Autores principales: | Rabbani, Naila, Xue, Mingzhan, Thornalley, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975768/ https://www.ncbi.nlm.nih.gov/pubmed/27406712 http://dx.doi.org/10.1007/s10719-016-9705-z |
Ejemplares similares
-
Dicarbonyl stress, protein glycation and the unfolded protein response
por: Rabbani, Naila, et al.
Publicado: (2021) -
Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022) -
Glycolytic overload-driven dysfunction of periodontal ligament fibroblasts in high glucose concentration, corrected by glyoxalase 1 inducer
por: Ashour, Amal, et al.
Publicado: (2020) -
Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome
por: Alhujaily, Muhanad, et al.
Publicado: (2021) -
Dicarbonyl stress in clinical obesity
por: Masania, Jinit, et al.
Publicado: (2016)